Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
114,000
Employees114,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
114,000
Employees114,000

ABT Key Statistics

Market cap
219.40B
Market cap219.40B
Price-Earnings ratio
15.93
Price-Earnings ratio15.93
Dividend yield
1.86%
Dividend yield1.86%
Average volume
5.07M
Average volume5.07M
High today
$128.10
High today$128.10
Low today
$126.06
Low today$126.06
Open price
$126.80
Open price$126.80
Volume
4.19M
Volume4.19M
52 Week high
$141.23
52 Week high$141.23
52 Week low
$110.86
52 Week low$110.86

Stock Snapshot

As of today, Abbott(ABT) shares are valued at $126.18. The company's market cap stands at 219.4B, with a P/E ratio of 15.93 and a dividend yield of 1.9%.

During the trading session on 2026-01-08, Abbott(ABT) shares reached a daily high of $128.10 and a low of $126.06. At a current price of $126.18, the stock is +0.1% higher than the low and still -1.5% under the high.

Trading volume for Abbott(ABT) stock has reached 4.19M, versus its average volume of 5.07M.

The stock's 52-week range extends from a low of $110.86 to a high of $141.23.

The stock's 52-week range extends from a low of $110.86 to a high of $141.23.

ABT News

Simply Wall St 1d
Is Abbott Laboratories Pricing Look Attractive After Recent Steady Multi‑Year Returns

If you have been wondering whether Abbott Laboratories at around US$127.78 is offering fair value or a premium price, this breakdown is designed to give you a c...

Is Abbott Laboratories Pricing Look Attractive After Recent Steady Multi‑Year Returns
Simply Wall St 2d
Abbott’s New Libre Assist AI Tool Might Change The Case For Investing In Abbott Laboratories

In early January 2026, Abbott Laboratories launched Libre Assist, an AI-powered feature within its Libre diabetes app that uses food photos or text descriptions...

Abbott’s New Libre Assist AI Tool Might Change The Case For Investing In Abbott Laboratories
Nasdaq 3d
Abbott Laboratories Launches Libre Assist To Deliver Personalized Meal Guidance

(RTTNews) - Abbott Laboratories (ABT), Monday announced the launch of Libre Assist, a new feature within the Libre app designed to help people with diabetes in...

Abbott Laboratories Launches Libre Assist To Deliver Personalized Meal Guidance

Analyst ratings

68%

of 31 ratings
Buy
67.7%
Hold
32.3%
Sell
0%

More ABT News

Simply Wall St 6d
Returns On Capital Are Showing Encouraging Signs At Abbott Laboratories

What are the early trends we should look for to identify a stock that could multiply in value over the long term? One common approach is to try and find a compa...

Returns On Capital Are Showing Encouraging Signs At Abbott Laboratories

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.